Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.
Maraninchi D, Vey N, Viens P, Stoppa AM, Archimbaud E, Attal M, Baume D, Bouabdallah R, Demeoq F, Fleury J, Michallet M, Olive D, Reiffers J, Sainty D, Tabilio A, Tiberghien P, Brandely M, Hercend T, Blaise D. Maraninchi D, et al. Among authors: reiffers j. Leuk Lymphoma. 1998 Oct;31(3-4):343-9. doi: 10.3109/10428199809059227. Leuk Lymphoma. 1998. PMID: 9869198 Clinical Trial.
The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission.
Blaise D, Attal M, Pico JL, Reiffers J, Stoppa AM, Bellanger C, Molina L, Nedellec G, Vernant JP, Legros M, Gabus R, Huguet F, Brandely M, Hercend T, Olive D, Maraninchi D. Blaise D, et al. Among authors: reiffers j. Leuk Lymphoma. 1997 May;25(5-6):469-78. doi: 10.3109/10428199709039034. Leuk Lymphoma. 1997. PMID: 9250817 Clinical Trial.
Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.
Blaise D, Attal M, Reiffers J, Michallet M, Bellanger C, Pico JL, Stoppa AM, Payen C, Marit G, Bouabdallah R, Sotto JJ, Rossi JF, Brandely M, Hercend T, Maraninchi D. Blaise D, et al. Among authors: reiffers j. Eur Cytokine Netw. 2000 Mar;11(1):91-8. Eur Cytokine Netw. 2000. PMID: 10705305 Free article. Clinical Trial.
Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT Study Group.
Jourdan E, Reiffers J, Stoppa AM, Sotto JJ, Attal M, Bouabdallaha R, Marit G, Fégueux N, Boulat O, Dastugue N, Boiron JM, Fabères C, Gastaut JA, Maraninchi D, Blaise D; BGMT Study Group. Jourdan E, et al. Among authors: reiffers j. Leuk Lymphoma. 2001 Jun;42(1-2):57-65. doi: 10.3109/10428190109097676. Leuk Lymphoma. 2001. PMID: 11699222
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation.
Mohty M, Bilger K, Jourdan E, Kuentz M, Michallet M, Bourhis JH, Milpied N, Sutton L, Jouet JP, Attal M, Bordigoni P, Cahn JY, Sadoun A, Ifrah N, Guyotat D, Faucher C, Fegueux N, Reiffers J, Maraninchi D, Blaise D. Mohty M, et al. Among authors: reiffers j. Leukemia. 2003 May;17(5):869-75. doi: 10.1038/sj.leu.2402909. Leukemia. 2003. PMID: 12750699
425 results